Liver xenotransplantation: Changes in lipid and lipoprotein concentration after long-term graft survival

Journal of Hepatology

Volumn 32, Issue 4, 2000, Pages 655-660

  Molleví, David G ^b   Jaurrieta, Eduardo ^c   Ribas, Yolanda ^c   Hurtado, Isabel ^c   Serrano, Teresa ^a   Gómez, Neus ^c   Oca, Javier De ^c   Fiol, Concepció ^c   Figueras, Joan ^c  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b Dept Cir I Especialitats Q   (Spain)

^c NONE

Author keywords

Cholesterol; Lipoprotein; Liver; Metabolism; Xenotransplantation

Indexed keywords

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOARCHITECTURE; ENZYME REGULATION; GRAFT SURVIVAL; LIPID BLOOD LEVEL; LIPID COMPOSITION; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; LIVER METABOLISM; LIVER TRANSPLANTATION; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; ULTRACENTRIFUGATION; XENOTRANSPLANTATION;

EID: 0034027181     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80228-7     Document Type: Article

References (26)

1. Simon PM, Neethling FA, Taniguchi S, Goode PL, Zopf D, Hancock WW, et al. Intravenous infusion of αGal oligosaccharides in baboons delays hyperacute rejection of porcine heart xenografts. Transplantation. 65:1998;346-353.
2. Dalmasso AP, Vercellotti GM, Platt JL, Bach FH. Inhibition of complement-mediated endothelial cell cytotoxicity by decay accelerating factor: potential for prevention of xenograft hyperacute rejection. Transplantation. 52:1991;530-533.
3. Cozzi E, Yanoutsos N, Langford GA, Pino-Chavez G, Wallwork J, White DJG. Effect of transgenic expression of human decay accelerating factor on the inhibition of hyperacute rejection of pig organs. Cooper DKC, Kemp E. 2nd ed. Xenotransplantation. 1997;665 Springer, Heildelberg.
4. Leventhal JR, John R, Fryer JP, Witson JC, Derlich JM, Remiszewski J, et al. Removal of baboon and human anti-porcine IgG and IgM natural antibodies by immunoadsorption. Transplantation. 59:1995;294-300.
5. Pruitt SK, Kirk AD, Bollinger RR, Marsh HC, Collins BH, Levin JL, et al. The effect of soluble complement receptor type I on hyperacute rejection of porcine xenografts. Transplantation. 57:1994;363-370.
6. Kobayashi T, Kemp E, Cooper DKC. Prolongation of discordant xenograft survival by cobra venom factor. Cooper DKC, Kemp E. Xenotransplantation, 2nd ed. 1997;425 Springer, Heildelberg.
7. Magee JC, Collins BH, Harland RC, Lindman BJ, Bollinger RR, Frank MM, et al. Immunoglobulin prevents complement mediated hyperacute rejection in swine-to-primate xenotransplantation. J Clin Invest. 96:1995;2404-2412.
8. Chari RS, Collins BH, Magee JC, DiMaio M, Kirk AD, Harland RC, et al. Treatment of hepatic failure withex vivo pig-liver perfusion followed by liver transplantation. New Engl J Med. 331:1994;234-237.
9. Makowka L, Cramer DV, Hoffman A, Breda M, Sher L, Eiras-Hreha G, et al. The use of a pig liver xenograft for temporary support of a patient with fulminant hepatic failure. Transplantation. 59:1995;1654-1659.
10. Wernhold D, Weingartner J, Hammer C. In Vivo Investigation of Kangaroo Aortic Valve Xenoprostheses: an Experimental Animal Model. Yorke Med Books. 1986;669-683.
11. 3rd ed. West JB. Respiratory Physiology. 1985;Williams and Wilkins, Baltimore.
12. Siegel JB, Grey ST, Lesnikoski BA, Kopp CW, Soares M, Shulte J, et al. Xenogeneic endothelial cells activate human prothrombin. Transplantation. 64:1997;888-896.
13. Hammer C, Dommer S, Allmeling A. Cross species interaction of xenogeneic interleukins. Transplant Proc. 28:1996;858-859.
14. Lawson JH, Daniels LJ, Platt JL. The evaluation of thrombomodulin activity in porcine to human xenotransplantation. Transplant Proc. 29:1997;884-885.
15. Celli S, Valdivia LA, Kelly RH, Demetris AJ, Fung JJ, Rao AS, et al. Functional co-operation of xenoproteins after hamster-torat liver transplantation: with particular reference to hamster C3 and secretory component for rat IgA. Xenotransplantation. 2:1995;46-51.
16. Celli S, Valdivia LA, Fung JJ, Kelly RH, Pan F, Tsugita M, et al. Metabolic changes in the recipient after successful liver xenotransplantation in the rat. Transplant Proc. 26:1994;1207.
17. Gunsalus JR, Brady DA, Coulter SM, Gray BM, Edge ASB. Reduction of serum cholesterol in Watanabe rabbits by xenogeneic hepatocellular transplantation. Nature Med. 3:1997;48-53.
18. Spady DK, Dietschy JM. Sterol synthesisin vivo in 18 tissues of the squirrel monkey, guinea pig, rabbit, hamster and rat. J Lipid Res. 24:1983;303.
19. Ontko JA, Cheng Q, Yamamoto M. Metabolic factors underlying high serum triglycerides in the normal hamster. J Lipid Res. 31:1990;1983-1992.
20. Dietschy JM, Turley SD, Spady DK. Role of liver maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans. J Lipid Res. 34:1993;1637-1659.
21. Kamada N. Experimental liver transplantation. 1988;CRC Press, Boca Raton, FI.
22. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 34:1959;1345-1353.
23. Section D, General chemistry. Weast D, Astle MJ. Handbook of Chemistry and Physics. 1983;CRC Press, Boca Raton, Fl.
24. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of dyebinding. Anal Biochem. 72:1976;248-254.
25. Bell R, Ballas LM, Coleman RA. Lipid topogenesis. J Lipid Res. 22:1981;391-403.
26. Hammer C. Barreras naturales frente al xenotrasplante. Arias M, Gómez-Fleitas M, De Francisco ALM. Xenotrasplante. 1994;113-126 Sandoz, Barcelona.